Breast Cancer
A Phase III Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women with Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
Trial ID: 07132
Contact: Carolyn Cox
Phone: (281)863-6641
Learn More about this trial.
go back | new search